Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Other 1Gynecologic 1Breast 1

Conditions

Weight Loss 1Polycystic Ovary Syndrome 1Overweight 1Ovarian Neoplasms 1Obesity 1Neoplasms 1Infertility 1Fasting 1Breast Neoplasms 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Diet, Vegan × Clear all
NCT03162289 2022-12-13

FIT2

Charite University, Berlin, Germany

Phase NA Unknown
150 enrolled
BreastGynecologic

Breast Neoplasms, Fasting, Ovarian Neoplasms

NCT01716429 2019-04-18

HER Health

University of South Carolina

Phase NA Withdrawn
Other

Infertility, Obesity, Polycystic Ovary Syndrome, Weight Loss, Overweight

NCT02437474 2017-11-07

Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot Study

Verein Essen und Krebs

Completed
326 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡